Gene Score, Endocrine Response Can Guide Early Breast Cancer Therapy

(MedPage Today) -- Use of the 21-gene recurrence score (RS) combined with response to 3-week preoperative endocrine therapy can be used to guide systemic therapy in early breast cancer patients with limited nodal involvement, and can help avoid...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news